Improving Frailty in Patients With Stable Ischemic Heart Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: physiotherapy.
- Who it may be relevant to
- Registry conditions: Coronary Heart Disease. Basic parameters: from 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of a Program Aimed at Improving Frailty in Patients With Stable Ischemic Heart Disease in Primary Care: Fragicor Study
Overview
The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease . Researchers will determine the improvement in the instability and the strength along twelve sessions based on guided exercises and mobility techniques made by physiotherapists. Research team will also evaluate the medications and diet, as well as laboratory and clinical tests.
Detailed description
Intitial visit to measure quality of life, instability and strenght, followed by twelve sessions, one each week will be performed
Interventions
- Other physiotherapy
Primary care based physiotherapy groups
Primary outcome measures
- Short Physical Performance Battery (SPPB) components (balance, gait speed, chair rise) [Time frame: From enrollment to the end of treatment ending after 12 weeks.]
Secondary outcome measures (1)
- Euroqol5D Goldberg Anxiety and Depression Scale Number of falls throughout the study Major Cardiovascular events Adherence to the program [Time frame: from the baseline to 12 weeks of intervention]
Eligibility criteria
Inclusion criteria
- Age ≥ 70 years
- Diagnosis of coronary artery disease (International Classification Diseases (ICD)-10 I20-I25)
- Canadian Cardiovascular Society Class I
- Low cardiovascular risk according to exclusion criteria
Exclusion criteria
- Inability or refusal to provide informed consent (advanced dementia, severe psychiatric illness)
- Inability to perform protocol procedures
- Severe mobility-limiting conditions (Parkinson's disease, progressive neurological disorders, disabling joint disease)
- Recent (<6 months) unstable angina, myocardial infarction, coronary revascularization or angioplasty
- Deep venous thrombosis or pulmonary embolism in the last 6 months
- Recent stroke (<6 months)
- Heart failure in New York Heart Assocaition functional status (NYHA) III-IV
- Left ventricular ejection fraction < 50%
- Symptomatic valvular heart disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
Spain · 1 center
- Primary Care Centers — Barcelona
Identifiers
NCT: NCT07373119 · ethics committee 25/198-P · Ajuts XB